A scaffold replacement approach towards new sirtuin 2 inhibitors

• Published in: Bioorganic & medicinal chemistry 2020-01, Vol.28 (2), p.115231, Article 115231
• Main Authors: Seifert, Tina, Malo, Marcus, Kokkola, Tarja, Stéen, E. Johanna L., Meinander, Kristian, Wallén, Erik A.A., Jarho, Elina M., Luthman, Kristina
• Format: Article
• Language: English
• Subjects: 1-dioxide; 1-dioxides; Benzothiadiazine-1; Benzothiadiazine-1,1-dioxides; Benzothiazine-1; Benzothiazine-1,1-dioxide; Biochemistry & Molecular Biology; brain; Chemical Sciences; Chemistry; chroman-4-one; Chromones - chemical synthesis; Chromones - chemistry; Chromones - pharmacology; Docking; Dose-Response Relationship, Drug; Enzyme Inhibitors - chemical synthesis; Enzyme Inhibitors - chemistry; Enzyme Inhibitors - pharmacology; force-field; Humans; Inhibitor; Kemi; Models, Molecular; Molecular Structure; Pharmacology & Pharmacy; protein; Quinolin-4-one; Saccharin; Scaffold; SIRT2; Sirtuin; Sirtuin 2 - antagonists & inhibitors; Sirtuin 2 - metabolism; Structure-Activity Relationship
• ISSN: 0968-0896; 1464-3391
• DOI: 10.1016/j.bmc.2019.115231

[Display omitted] •Five heterocyclic core structures were explored as chroman-4-one/chromone bioisosteres.•Synthesis and biological evaluation of 24 new derivatives as potential SIRT2 inhibitors.•The new scaffolds provided improved physicochemical properties.•Benzothiadiazine-1,1-dioxide-based derivatives showed good SIRT2 inhibitory activity.•Two compounds showed high inhibitory activity also against SIRT3. Sirtuins (SIRT1–SIRT7) are an evolutionary conserved family of NAD+-dependent protein deacylases regulating the acylation state of ε-N-lysine residues of proteins thereby controlling key biological processes. Numerous studies have found association of the aberrant enzymatic activity of SIRTs with various diseases like diabetes, cancer and neurodegenerative disorders. Previously, we have shown that substituted 2-alkyl-chroman-4-one/chromone derivatives can serve as selective inhibitors of SIRT2 possessing an antiproliferative effect in two human cancer cell lines. In this study, we have explored the bioisosteric replacement of the chroman-4-one/chromone core structure with different less lipophilic bicyclic scaffolds to overcome problems associated to poor physiochemical properties due to a highly lipophilic substitution pattern required for achieve a good inhibitory effect. Various new derivatives based on the quinolin-4(1H)-one scaffold, bicyclic secondary sulfonamides or saccharins were synthesized and evaluated for their SIRT inhibitory effect. Among the evaluated scaffolds, the benzothiadiazine-1,1-dioxide-based compounds showed the highest SIRT2 inhibitory activity. Molecular modeling studies gave insight into the binding mode of the new scaffold-replacement analogues.